peoplePerson
Gary H. Lyman
Gary Lyman is an oncologist and health economist behind guidelines on growth factors, thrombosis, and biosimilars in cancer care.
Medical oncologist and epidemiologist who chaired ASCO guidelines on neutropenia, venous thromboembolism, and biosimilars, and directs Fred Hutch's comparative effectiveness research.
Role
Professor, Public Health Sciences and Clinical Research Divisions, Fred Hutchinson Cancer Center
Institution
Specialisms
Supportive careHealth economicsComparative effectiveness
| Title | Journal | Year |
|---|---|---|
| Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update | Journal of Clinical Oncology | 2020 |
| Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update | Journal of Clinical Oncology | 2015 |
Pages like this
not linked directly; found by shared links- IdeaA dedicated programme for cachexia and treatment toxicity research
Shares Cardio-oncology, Geriatric assessment.
- TechnologyExercise during chemotherapy and radiotherapy
Shares Cardio-oncology, Geriatric assessment.
- InstitutionMultinational Association of Supportive Care in Cancer
Shares Cardio-oncology, Geriatric assessment.
- PathwayCancer cachexia
- TechnologySurvivorship care and late-effects surveillance
Shares Cardio-oncology, Geriatric assessment.
- RoadmapPaths to cures: interception, eradication, control
Shares Cardio-oncology, Geriatric assessment.